Cognizant

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Cognizant will provide AI-driven solutions to enhance customer service, employee engagement, and business value 30 January 2025 — New Jersey, US — Cognizant has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences that aims to unlock even greater value for Gilead as it advances innovations to prevent and treat life-threatening diseases. The…

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant’s AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors 19 March 2024 – London, UK – Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex…

Cognizant Shared Investigator Platform for Life Sciences Reaches Major Milestone in Accelerating Drug Discovery

Cognizant (Nasdaq: CTSH) announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution, has reached a new milestone of over 100,000 users in 84 countries. The platform has become increasingly critical to progressing clinical trials as prevailing social distancing norms have significantly curtailed in-person collaboration.